4//SEC Filing
Basi Guriqbal S. 4
Accession 0001209191-18-017787
CIK 0000873303other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 6:00 PM ET
Size
5.8 KB
Accession
0001209191-18-017787
Insider Transaction Report
Form 4
Basi Guriqbal S.
SVP, Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2018-03-05+70,000→ 70,000 totalExercise: $71.45Exp: 2028-03-05→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001717540
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 6:00 PM ET
- Size
- 5.8 KB